MultNAT® Gastrointestinal Panel
Ongoing Challanges
- Acute gastroenteritis is a leading cause of morbidity and mortality worldwide, particularly in at-risk populations, such as children, older individuals, and immunocompromised patients.
- Rotavirus and Escherichia coli are the two most common etiological agents of moderate-to-severe diarrhea in low-income countries. Other pathogens, such as Cryptosporidium and Shigella species, may also be important.
- Antibiotics (e.g., Ciprofloxacin, Metronidazole, Doxycycline) are effective in the treatment of shigellosis, campylobacteriosis, clostridium difficile, traveler’s diarrhea, and protozoal infections.
- A study proved that the use of antibiotics in the early stages of diarrhea has been shown to increase the risk of hemolytic uremic syndrome (HUS), which means clinicians will need a quick and precise result for subsequent treatment of patients suffering from contagious diarrhea.
Product Overview
MultNAT® Gastrointestinal Panel is a comprehensive and flexible multiplex molecular RT-PCR testing right to the point of care on 24 diarrhea-related targets in a single stool sample, contributing to fast diagnosis and precise evidence-based therapy.
- Result less than 80 min for 24 targets.
- Easy to use and control the hands-on time within 2mins
- Point-of-care Nucleic Acid Testing applicable across diverse medical settings.
- Comprehensive detection of 24 distinct targets supports physicians in prescribing targeted treatments.
The following 24 gastrointestinal targets are identified using this product:
Clinical Value
- Well-suited for multiplex testing on diarrheal disease, which has a broad range of potential pathogens.
- Facilitate targeted and antimicrobial therapy.
- Save time and labor for downstream procedures.
- Avoid antibiotic abuse.
Product Resources
MultNAT® Gastrointestinal Panel
Brochure
MultNAT® Gastrointestinal Panel
Instructions for Use
MultNAT® Gastrointestinal Panel
SOP
